Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-11, with 69 holding rows worth $4,844,538,000.

Accession
0001140361-16-075939
Filed
2016-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 70 entries on the cover page, a total value of $4,844,538,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,844,538,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BLUE BUFFALO PET PRODS INC09531U102COM114,987,547$2,683,809,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK57,517,977$825,383,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM29,443,300$342,426,000thousands by filing date
Goldman Sachs Group,Inc.38141G104COM1,250,000$185,725,000thousands by filing datecall
Bank of America Corp060505104COM5,000,000$66,350,000thousands by filing datecall
INCYTE CORP COM45337C102Stock625,000$49,988,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock120,000$41,908,000thousands by filing datecall
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock710,000$39,398,000thousands by filing date
Walmart Inc.931142103COM500,000$36,510,000thousands by filing datecall
BIOGEN INC COM09062X103Stock150,000$36,273,000thousands by filing datecall
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS400,000$31,812,000thousands by filing date
Goldman Sachs Group,Inc.38141G104COM200,000$29,716,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM40,000$28,141,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM350,000$27,230,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM1,400,000$19,922,000thousands by filing date
METLIFE INC COM59156R108Stock500,000$19,915,000thousands by filing datecall
CELGENE CORP151020104COM200,000$19,726,000thousands by filing datecall
BLUEBIRD BIO INC09609G100COM450,000$19,481,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock50,000$17,462,000thousands by filing date
DELPHI AUTOMOTIVE PLCG27823106COMMON STOCK-FO275,000$17,215,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock300,000$16,647,000thousands by filing datecall
KITE PHARMA INC49803L109COM325,000$16,250,000thousands by filing date
Tesla Motors, Inc88160R101COM75,000$15,921,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM375,000$15,711,000thousands by filing date
JPMorgan Chase & Co46625H100COM250,000$15,535,000thousands by filing datecall
International Business Machines Corporation459200101COM100,000$15,178,000thousands by filing datecall
Bank of America Corp060505104COM1,100,000$14,597,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock3,870,000$13,777,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM150,000$12,903,000thousands by filing datecall
US FOODS HLDG CORP COM912008109Stock500,000$12,120,000thousands by filing date
Citigroup Inc.172967424COM250,000$10,598,000thousands by filing date
Morgan Stanley617446448COM400,000$10,392,000thousands by filing date
METLIFE INC COM59156R108Stock250,000$9,958,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM310,000$9,006,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM200,000$7,688,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,250,000$6,825,000thousands by filing date
SPECTRANETICS CORP84760C107COM350,000$6,549,000thousands by filing date
AVEXIS INC05366U100COM161,900$6,155,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS350,000$5,765,000thousands by filing date
CELLECTIS ADS15117K103COM210,000$5,584,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR250,000$5,308,000thousands by filing datecall
INTELLIA THERAPEUTICS INC45826J105COM225,000$4,804,000thousands by filing date
BLUEBIRD BIO INC09609G100COM100,000$4,329,000thousands by filing datecall
NEUROCRINE BIOSCIENCES INC64125C109COM95,000$4,318,000thousands by filing date
IGNYTA INC451731103COM750,000$4,065,000thousands by filing date
AGENUS INC00847G705COM NEW1,000,000$4,050,000thousands by filing date
CHEMOCENTRYX INC16383L106COM900,000$4,041,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW100,000$3,675,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW100,000$3,675,000thousands by filing datecall
ULTRAGENYX PHARMACEUTICAL IN90400D108COM75,000$3,668,000thousands by filing date
ACCELERON PHARMA INC00434H108COM100,000$3,398,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS1,282,050$3,346,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM100,000$3,013,000thousands by filing datecall
CELLDEX THERAPEUTICS INC NEW15117B103COM675,000$2,963,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK216,879$2,836,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM50,000$2,557,000thousands by filing date
OPHTHOTECH CORP683745103COM50,000$2,552,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM125,000$2,074,000thousands by filing date
AGENUS INC00847G705COM NEW500,000$2,025,000thousands by filing datecall
JUNO THERAPEUTICS INC48205A109COM50,000$1,922,000thousands by filing datecall
SAREPTA THERAPEUTICS INC803607100COM100,000$1,907,000thousands by filing datecall
DIMENSION THERAPEUTICS INC25433V105COM275,000$1,650,000thousands by filing date
CEMPRA INC15130J109COM100,000$1,649,000thousands by filing date
REGENXBIO INC75901B107COM200,000$1,600,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM1,000,000$1,490,000thousands by filing date
NANTKWEST INC63016Q102COM225,000$1,400,000thousands by filing date
CERES INC156773400COM NEW1,024,020$400,000thousands by filing date
ONCOCYTE CORP68235C107COM64,102$228,000thousands by filing date
COLUCID PHARMACEUTICALS INC19716T101COM5,575$46,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-16-075939this filing2016-08-11acceptance time not in the bulk data set